Jeffrey Lieberman
Jeffrey Lieberman
Professor of Psychiatry Columbia University
Verified email at - Homepage
Cited by
Cited by
Le capital
K Marx
Librairie du progrès, 1875
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ...
New England journal of medicine 353 (12), 1209-1223, 2005
Practice guideline for the treatment of partients with schizophrenia
AF Lehman, JA Lieberman, LB Dixon, TH McGlashan, AL Miller, ...
American Journal of psychiatry 161 (2 SUPPL.), i-iv+ 1-56, 2004
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
SH Lee, S Ripke, BM Neale, SV Faraone, SM Purcell, RH Perlis, ...
Nature genetics 45 (9), 984, 2013
Genome-wide association study identifies five new schizophrenia loci
S Ripke, AR Sanders, KS Kendler, DF Levinson, P Sklar, PA Holmans, ...
Nature genetics 43 (10), 969, 2011
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
D Robinson, MG Woerner, JMJ Alvir, R Bilder, R Goldman, S Geisler, ...
Archives of general psychiatry 56 (3), 241-247, 1999
Biological insights from 108 schizophrenia-associated genetic loci
S Ripke, BM Neale, A Corvin, JTR Walters, KH Farh, PA Holmans, P Lee, ...
Nature 511 (7510), 421-427, 2014
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia …
JP McEvoy, JM Meyer, DC Goff, HA Nasrallah, SM Davis, L Sullivan, ...
Schizophrenia research 80 (1), 19-32, 2005
Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis
DO Perkins, H Gu, K Boteva, JA Lieberman
American journal of psychiatry 162 (10), 1785-1804, 2005
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
LS Schneider, PN Tariot, KS Dagerman, SM Davis, JK Hsiao, MS Ismail, ...
New England Journal of Medicine 355 (15), 1525-1538, 2006
Duration of psychosis and outcome in first-episode schizophrenia.
AD Loebel, JA Lieberman, JM Alvir, DI Mayerhoff, SH Geisler, ...
The American journal of psychiatry, 1992
Clozapine-induced agranulocytosis--incidence and risk factors in the United States
JMJ Alvir, JA Lieberman, AZ Safferman, JL Schwimmer, JA Schaaf
New England Journal of Medicine 329 (3), 162-167, 1993
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates
RM Bilder, RS Goldman, D Robinson, G Reiter, L Bell, JA Bates, ...
American Journal of Psychiatry 157 (4), 549-559, 2000
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto, GE Duncan, CE Marx, JA Lieberman
Molecular psychiatry 10 (1), 79-104, 2005
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ...
American Journal of Psychiatry 163 (4), 600-610, 2006
Physical health monitoring of patients with schizophrenia
SR Marder, SM Essock, AL Miller, RW Buchanan, DE Casey, JM Davis, ...
American Journal of Psychiatry 161 (8), 1334-1349, 2004
Catching up on schizophrenia: natural history and neurobiology
DA Lewis, JA Lieberman
Neuron 28 (2), 325-334, 2000
Practice guideline for the treatment of patients with borderline personality disorder
American Psychiatric Association
American Psychiatric Pub, 2001
Pharmacology of the lower urinary tract
KE Andersson, C Gratzke
Textbook of the neurogenic bladder 2, 81-100, 2008
The system can't perform the operation now. Try again later.
Articles 1–20